Open $213.27
Day Range 198.00 - 213.49
52 Week Range 54.21 - 227.71
Market Cap $87.87B
Shares Outstanding 401.53M
Public Float 342.09M
Beta 0.29
Rev. per Employee $618.00K
P/E Ratio 164.33
EPS $1.25
Yield N/A
Dividend N/A
Ex-Dividend Date N/A
Short Interest 11.83M 05/28/21
% of Float Shorted 3.46%
Average Volume 9.45M

5 Day	-6.98%
1 Month	27.31%
3 Month	42.18%
YTD	95.51%
1 Year	206.82%

Sell
Under
Hold
Over
Buy

Number of Ratings 18 Full Ratings

MarketWatch
Dow Jones

Barron's

Novavax’s Study Showed Its Covid-19 Vaccine Works. Why Moderna Stock Is Down.

Jun. 14, 2021 at 6:40 a.m. ET by Barron's

Moderna hires J&J executive as chief medical officer

Jun. 14, 2021 at 8:28 a.m. ET by Jaimy Lee

Moderna Taps J&J Executive Burton as Medical Chief

Jun. 14, 2021 at 8:20 a.m. ET

Burton comes to Moderna after 16 years with Johnson & Johnson

Jun. 14, 2021 at 8:12 a.m. ET by Ciara Linnane

Moderna names Dr. Paul Burton chief medical officer

Jun. 14, 2021 at 8:12 a.m. ET by Ciara Linnane

Moderna Submits Application for Covid-19 Vaccine in Adolescents in Switzerland

Jun. 14, 2021 at 7:20 a.m. ET

Novavax reports COVID-19 vaccine was 90% effective in Phase 3 study

Jun. 14, 2021 at 6:12 a.m. ET by Steve Goldstein

New U.S. COVID-19 cases and deaths jump to two weeks highs

Jun. 12, 2021 at 9:32 a.m. ET by Tomi Kilgore

Moderna Inc. stock outperforms market on strong trading day

Jun. 11, 2021 at 4:31 p.m. ET by MarketWatch Automation

New daily COVID-19 cases and deaths fall for first time in 4 days, while vaccine concerns grow with reports of side effects

Jun. 11, 2021 at 12:52 p.m. ET by Tomi Kilgore

Barron's

CureVac Stock Drops on Worries Over Vaccine Trial Delay

Jun. 11, 2021 at 11:23 a.m. ET by Barron's

Moderna and Tabuk Partner to Commercialize Moderna Covid-19 Vaccine in Saudi Arabia

Jun. 11, 2021 at 8:59 a.m. ET

Moderna Inc. stock underperforms Thursday when compared to competitors

Jun. 10, 2021 at 4:31 p.m. ET by MarketWatch Automation

New daily COVID-19 cases rise back above 20,000, as cases and deaths increase for 3rd straight day

Jun. 10, 2021 at 12:09 p.m. ET by Tomi Kilgore

Moderna files for its COVID-19 vaccine to be granted emergency use in adolescents

Jun. 10, 2021 at 8:14 a.m. ET by Tomi Kilgore

Moderna Requests U.S. Emergency-Use Authorization for Covid-19 Vaccine in Adolescents

Jun. 10, 2021 at 8:28 a.m. ET

Moderna files for EUA for COVID-19 vaccine in adolescents

Jun. 10, 2021 at 8:02 a.m. ET by Tomi Kilgore

Moderna Inc. stock rises Wednesday, outperforms market

Jun. 9, 2021 at 4:31 p.m. ET by MarketWatch Automation

New daily COVID-19 cases and deaths rise again as concerns over delta variant and Biden vaccination target for July 4 increase

Jun. 9, 2021 at 12:21 p.m. ET by Tomi Kilgore

Moderna Inc. stock underperforms Tuesday when compared to competitors

Jun. 8, 2021 at 4:31 p.m. ET by MarketWatch Automation

No Headlines Available

Other News
Press Releases

AstraZeneca (AZN) COVID-19 Jab's New Side Effect Stated by EMA

Jun. 14, 2021 at 10:23 a.m. ET on Zacks.com

Monday’s Pre-Market: Here’s What You Need to Know Before the Market Opens

Jun. 14, 2021 at 8:42 a.m. ET on TipRanks.com

These 3 Stocks Will Make You Richer in 2021 (and Beyond)

Jun. 14, 2021 at 6:15 a.m. ET on Motley Fool

Will This News Stop Ocugen Shares in Their Tracks?

Jun. 14, 2021 at 6:00 a.m. ET on Motley Fool

Moderna Inks Partnership Deal with Tabuk Pharmaceuticals

Jun. 14, 2021 at 3:26 a.m. ET on TipRanks.com

3 Reasons to Buy Moderna, and 1 Reason to Sell

Jun. 13, 2021 at 6:00 a.m. ET on Motley Fool

Science Sides with Pfizer, Despite Vaccine Fears

Jun. 13, 2021 at 5:55 a.m. ET on TipRanks.com

3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort

Jun. 13, 2021 at 5:11 a.m. ET on Motley Fool

Ocugen (OCGN) to File Coronavirus Vaccine BLA in US, Stock Tanks

Jun. 11, 2021 at 11:51 a.m. ET on Zacks.com

Friday’s Pre-Market: Here’s What You Need to Know Before the Market Opens

Jun. 11, 2021 at 9:17 a.m. ET on TipRanks.com

COVID-19 Jabs of Pfizer & Moderna May Lead to Inflamed Heart

Jun. 11, 2021 at 8:44 a.m. ET on Zacks.com

Which Company Will Dominate the Teen Vaccination Market This Fall?

Jun. 11, 2021 at 6:15 a.m. ET on Motley Fool

Moderna Seeks Emergency Use Authorization for COVID-19 Vaccine in Adolescents

Jun. 11, 2021 at 3:50 a.m. ET on TipRanks.com

ETFs to Win as Moderna Seeks COVID-19 Vaccine Nod for Teens

Jun. 10, 2021 at 6:00 p.m. ET on Zacks.com

CDC Finds Higher-Than-Expected Heart Inflammation Cases in Young Men Following COVID Vaccine Jabs

Jun. 10, 2021 at 5:47 p.m. ET on Motley Fool

Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

Jun. 10, 2021 at 5:45 p.m. ET on Zacks.com

Moderna Files for FDA Approval of Its COVID Vaccine in Teens

Jun. 10, 2021 at 2:00 p.m. ET on Motley Fool

Why Shares of Novavax Crashed 37.7% in May

Jun. 10, 2021 at 12:07 p.m. ET on Motley Fool

Why Shares of Vaxart Plummeted 38.6% in May

Jun. 10, 2021 at 11:59 a.m. ET on Motley Fool

How Does Moderna Measure up to Bigger Rival Pfizer?

Jun. 10, 2021 at 6:30 a.m. ET on Motley Fool

No Headlines Available

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.